First Herceptin biosimilar cleared in Europe
Ontruzant is approved for all the same indications as Roche s blockbuster
EMA forges closer ties with HTA umbrella group
Agrees joint work plan with the European Network for Health Technology Assessment
Novartis’ orphan drug Tasigna wins EU expanded indication
The CML medication can now treat paediatric patients
Amsterdam picked to host the European Medicines Agency
But regulator faces a challenging relocation project to depart from London
Concordia accused of overcharging NHS for thyroid drug
The pharma firm said to have abused its position within the UK market
The state of trust
Roche s Future-proofing Healthcare event shows how the current model is a complicated one
Revolutionising how healthcare is delivered
The big technology shift sweeping the global connection of healthcare
A visual showcase of agency work. Track down an agency from the image, track down your competitors’ work, search by product or therapy area to pull up, for example, cardiovascular campaigns. Click here for a portfolio of hundreds of campaign visuals – updated regularly – free for you to reference. Agencies – to add your work to The Gallery please contact us.
MHRA joins Instagram as part of Yellow Card drive
UK medicines regulator follows in the footsteps of NICE in using the channel
Annalisa Jenkins joins biomarker firm PlaqueTec as CEO
She arrives from US-based Dimension Therapeutics, where she was CEO
Is AI changing the future of healthcare?
How technology is playing a big role in healthcare
Proving the Strategic Value of Patients
Tony de Fougerolles joins Evox Therapeutics as CEO
He succeeds Dr Per Lundin who stays at the firm as COO
Teva launches personalised digital support for MS patients
Says its MS Care Programme is the first of its kind
What value for innovation in an era dominated by affordability?
Pharma can collaborate but must be clear about its motives
The Future of Marketing in Life Sciences: Is your function fit for purpose
Do you want to see a magic trick?
Key points that drive behaviour change